Advertisement

Advertisement

Op-Ed

Advertisement

Advertisement

Apr

19

Today In Oncology

Study Finds Medicaid Reimbursement for Radiation Therapy Varies Widely State-to-State

Complementary and Alternative Medicine Use in Patients With Cancer

KEYNOTE-158: Pembrolizumab in Previously Treated Advanced Cervical Cancer

Addition of Radiotherapy After Breast-Conserving Surgery Based on Level of Tumor-Infiltrating Lymphocytes

Addition of Bortezomib to R-CHOP in DLBCL Subtypes Identified With Gene-Expression Profiling

;

Advertisement

Most Read Stories

Factors Contributing to Improved Survival Following Total Neoadjuvant Therapy for Borderline/Locally Advanced Pancreatic Cancer

FDA Pipeline: Designation in Uveal Melanoma, Application for MDS Side-Effect Management

Treatment of Patients With Imminently Fatal de Novo Metastatic Cancer

How I Work up the Patient with Thrombocytosis

Paclitaxel or Cisplatin Plus Fluorouracil in Chemoradiotherapy for Locally Advanced Esophageal Cancer

Most Viewed Videos

Eva M. Ciruelos, MD, PhD, on HER2-Positive Breast Cancer: Results From the PATRICIA Trial

Bruce D. Cheson, MD, and Richard I. Fisher, MD, on Lymphoma: Treatment Considerations

Mark K. Ferguson, MD, on Mitigating Frailty and Sarcopenia to Improve Treatment Outcomes

Jyoti D. Patel, MD, on Stage III Non–Small Cell Lung Cancer: A Look at New Systemic Treatments

Nicholas Vogelzang, MD, on Urothelial Cancer: Results From a Trial on Lenvatinib Plus Pembrolizumab

© 2019 HSP News Service, L.L.C.